RobertTsuntzeChenMDMA

PubMed

• 15 citations
  Evaluation of vaccine safety after the events of 11 September 2001: role of cohort and case-control studies
  Robert T. Chen
  Vaccine. 2004-05-07
• 10 citations
  Enhancing vaccine safety capacity globally: A lifecycle perspective.
  Robert T Chen, Tom T Shimabukuro, David B Martin, Patrick L F Zuber, Daniel M Weibel
  Vaccine. 2015-11-27
• 9 citations
  Laboratory-based performance evaluation of PIMA CD4 + T-lymphocyte count point-of-care by lay-counselors in Kenya
  Clement Zeh, Charles E. Rose, Seth C Inzaule, Mitesh Desai, Fredrick Otieno
  Journal of Immunological Methods. 2017-09-01

Journal Articles

• Distastefulness as a defense mechanism in Aplysia braziliana.  
  Ambrose HW, Givens RP, Chen R, Ambrose KP, Marine Behavior and Physiology. 1971; 6:57_64
• Child health policy _ an overview of federal involvement.  
  Berkelhamer JE, Noyes EJ, Chen RT, Advances in Pediatrics, 29:211_28, l982
• Diphtheria in the United States, l971_l981.  
  Chen RT, Broome CV, Weinstein RA, Weaver R, Tsai TF, Am J Public Health 1985; 75:1393_97
• Tetanus prophylaxis in AIDS patients (letter).  
  Chen RT, Spira TJ, JAMA; l986, 255:l061
• Use of hospitals by patients with AIDS in San Francisco (letter).  
  Chen RT, Rutherford GW, Payne SF, Barnhart JL, Baskett LH, N Engl J Med 1988; 319:1671_1672
• An explosive point_source measles outbreak in a highly immunized population: modes of transmission and risk factors for disease.  
  Chen RT, Goldbaum GM, Wassilak SGF, Markowitz LE, Orenstein WA, Am J Epidemiol 1989;129:173_182
• Pertussis _ a disease and a vaccine that are not going away.  
  Orenstein WA, Bernier RH, Chen RT, West J Med 1989;150:339_341
• Projections of AIDS morbidity and mortality in San Francisco.  
  Lemp GF, Payne SF, Rutherford GW, Hessol NA, Winkelstein W, Wiley JA, Moss AR, Chaisson RE, Chen RT, Feigal DW, Thomas PA, Werdegar D, JAMA 1990;263:1497_1501
• Measles antibody: reevaluation of protective titers.  
  Chen RT, Markowitz LE, Albrecht P, Stewart JA, Mofenson LM, Preblud SR, Orenstein WA, J Infect Dis 1990; 162:1036-1042
• Confounding in studies of adverse reactions to vaccines.  
  Fine PEM, Chen RT, Am J Epidemiol 1992;136:121-35
• Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control.  
  Farizo KM, Strebel PM, Chen RT, Kimbler A, Cleary TJ, Cochi SL, Clin Infect Dis 1993;16:59-68
• Measuring vaccine efficacy from epidemics of acute infectious agents.  
  Longini IM, Halloran ME, Haber M, Chen RT, Statistics in Medicine 1993;12:249-63
• Outbreak of pyogenic abscesses after diphtheria and tetanus toxoids and pertussis vaccination.  
  Simon PA, Chen RT, Elliott JA, Schwartz B, Pediatr Infect Dis J 1993;12:368-71
• A "post-honeymoon period" measles outbreak in Muyinga Sector, Burundi.  
  Chen RT, Weierbach R, Bisoffi Z, Cutts F, Rhodes P, Ramaroson S, Ntembagara C, Bizimana F, Int J Epidemiol 1994;23:185-93
• The Vaccine Adverse Event Reporting System (VAERS).  
  Chen RT, Rastogi SC, Mullen JR, Hayes S, Cochi SL, Donlon JA, Wassilak SG, Vaccine 1994;12:542-50
• Surveillance of the safety of simultaneous administration of vaccines, the CDC experience.  
  Chen RT, Haber P, Mullen JR, Ann NY Acad Sci. 1995;754:309-20
• Utility of large-linked databases in vaccine safety, particularly in distinguishing independent and synergistic effects.  
  Wassilak SGF, Glasser JW, Chen RT, Hadler SC, and Vaccine Safety Datalink Investigators, Ann NY Acad Sci. 1995;754:377-82
• Reporting sensitivities of two passive surveillance systems for vaccine adverse events.  
  Rosenthal S, Chen RT, Am J Public Health. 1995;85:1706-9
• Children and international travel: immunizations.  
  Barnett ED, Chen R, Ped Infect Dis J. 1995;14:982-92
• Active surveillance for vaccine adverse effects (letter).  
  Chen RT, Lancet 1995;345:1369
• Vaccination in the immunocompromised person.  
  Grabowsky M, Hadler SC, Chen RT, Edwards KM, Bull Rheum Dis 1995;44:3_6
• The safety of acellular pertussis vaccine versus whole cell pertussis vaccine: a post-marketing assessment.  
  Rosenthal S, Chen R, Hadler SC, Arch Pediatr Adolesc Med. 1996;150:457-60
• An errant critique that misses the mark.  
  Chen RT, Rosenthal S, Arch Pediatr Adolesc Med. 1996;150:464-5
• Seroprevalence of Antibody Against Poliovirus in Inner-City Preschool Children: Implications for Vaccination Policy in the United States.  
  Chen RT, Hausinger S, Dajani AS, Hanfling M, et al, J Am Med Assoc 1996;276:1639-45
• Oral poliomyelitis vaccines.  
  Chen RT, Lancet 1996;347:1496. Letter
• Join now to see all

Books/Book Chapters

•  
  Chapter: Vigilancia epidemiologica de evento adversos despué de la vacunacion 
  Page 197 - 207Cordero JF, Chen REditors: Marti MC, Llop FAM.Prous Science, Barcelona
•  
  Chapter: Vaccine safety monitoring. 
  Iskander JK, Chen RTEditors: Sheikh NA, Davies DH, Schmidt C, Morrow, WJW.Wiley-Blackwell, OxfordEdition 1,
•  
  Chapter: Ch31: Rotavirus vaccines. 
  Page 745 - 749Sabin ME, Murphy TV, Chen RTEditors: Hartzema AG, Tilson HH, Chan KA.Harvey Whitney Books , CincinnatiEdition 1,
•  
  Chapter: Ch. 18: Vaccine preventable diseases PART 2: Public health surveillance for vaccine adverse events. 
  Page 241 - 253Iskander JK, Chen RTEditors: M'ikanatha NM, Lynfield R, Van Beneden CA, de Valk H.Wiley-Blackwell , OxfordEdition 1,
•  
  Chapter: Special Applications of Pharmacoepidemiology 
  Page 399 - 445Lee D, Majumdar SR, Lipton HL, Soumerai SB, Hennessy S, Davis RL, Chen RT, Bright RA, Mitchell AA, Graham DJ, Bates DW, and Strom BLEditors: Strom BL & Kimmel SE.John Wiley & Sons, Sussex
•  
  Chapter: Ch. 61: Safety of Immunizations. 
  Page 1557 - 1581Chen RT, Davis R, Sheedy KMEditors: Plotkin SA, Orenstein WA.W.B. Saunders, PhiladelphiaEdition 4,
•  
  Chapter: Evaluation of Immunization Programs. 
  Page 344 - 372Chen RT, Orenstein WAEditors: Thomas JC, Weber DJ.Oxford University Press , Oxford
•  
  Chapter: Challenges and Controversies in Immunization Safety. 
  Page 21 - 39Chen RT, DeStefano F, Pless R, Mootrey G, Kramarz P, Hibbs BEditors: Peter G, Gardner P.Peter G, Gardner P
•  
  Chapter: Vaccine safety and adverse events: key issues for health care workers. 
  Page 37 - 60Terracciano GJ, Chen REditors: Poland GA, Schaffner W, Pugliese G.Slack Inc, Thorofare, NJ
•  
  Chapter: Ch. 44: Vaccines for International Travel. 
  Page 1089 - 1106Barnett E, Chen RT, Rey MEditors: Plotkin SA, Orenstein WA.W.B. Saunders, PhiladelphiaEdition 3,
•  
  Chapter: Ch. 49: Safety of Vaccines. 
  Page 1144 - 1163Chen RTEditors: Plotkin SA, Orenstein WA.WB Saunders, PhiladelphiaEdition 3,
•  
  Chapter: Recent developments in vaccines for travellers: viral diseases. 
  Chen RT, Orenstein WAEditors: Lobel HO, Steffen R, Kozarsky PE.International Society of Travel Medicine, 1992:119-21, Atlanta, GA
•  
  Chapter: Vaccine preventable diseases: the commercially available vaccines. 
  Page 232 - 251Barnett ED, Chen RT, Rey MEditors: Dupont HL, Steffen R.Decker , MontrealEdition 2,
•  
  Chapter: Chapter 278: Corynebacterial infections. 
  Page 1627 - 1629Chen RT, Hardy IRBEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 3,
•  
  Terracciano G, Chen R, Lloyd JCenters for Disease Control and Prevention, Atlanta, GA
•  
  Chapter: Ch26: Special methodological issues in pharmacoepidemiology studies of vaccine safety. 
  Page 423 - 468Chen RT, Glanz, J, Vellozzi CEditors: Strom BL.John Wiley & Sons, SussexEdition 5,
•  
  Chapter: Diphtheria 
  Chen RTMcGraw_Hill, New YorkEdition 9,
•  
  Chapter: Corynebacterial infections. 
  Page 1377 - 1380Chen RTEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 2,
•  
  Chapter: Chapter 272: Corynebacterial infections. 
  Page 1984 - 1986Chen RTJ B Lippincott, PhiladelphiaEdition 4,
•  
  Chapter: Corynebacterial infections. 
  Page 1377 - 1380Chen RTEditors: Kelley WN.J B Lippincott, PhiladelphiaEdition 2,
•  
  Chapter: The Vaccine Adverse Event Reporting System (VAERS): a new resource for data on vaccine safety for travelers. 
  Chen RTEditors: Lobel HO, Steffen R, Kozarsky PE.Society of Travel Medicine, 1992:128-30, Atlanta, GA
• Join now to see all

Abstracts/Posters

• Monitoring of Vaccine Safety Inquiries: A New Tool for Vaccine Safety Signal Generation.
  Miller ER, Iskander JK, Haber P, Gangarosa P, Pool V, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Web-Based Reporting: 10 Months Experience in the Vaccine Adverse Event Reporting System (VAERS).
  Haber P, Rashidee A, Zhou W, English-Bullard R, the VAERS team, 19th International Conference on Pharmacoepidemiology, Philadelphia, PA
• Long-term risk of intussusception following Rhesus-human reassortant rotavirus tetravalent vaccine (RRV-TV).
  Rhodes PR, DeStefano F, Chen RT and the MCO RRV-TV Safety Cohort Study Group, 43rd ICAAC, Chicago, Illinois
• Age-associated risk of yellow fever vaccine-associated viscerotropic disease and neurotropic disease.
  Barwick RS, Marfin AA, Chen R, Simone P, Cetron MS and the Yellow Fever Vaccine Safety Working Group, Program and Abstracts of the IVth European Conference on Travel Medicine, Rome, Italy
• Clinical Assessment of Adverse Events Following Immunization (AEFIs): A Converging New International Paradigm?
  Casey CG, Campbell S, Iskander J,DeStefano F, Dekker CL, Gold MS,Zanoni G,Vermeer-de Bondt PE, Engler RJM, Chen RT Clinical Assessment of Adverse Events Following Immu..., 20th International Conference on Pharmacoepidemiology, Bordeaux, France
• Determining Risk of Multiple Sclerosis after Hepatitis B Vaccine: Time Since Vaccination and Source of Data.
  Frank DeStefano, Eric SWeintraub, Robert T Chen, 20th International Conference on Pharmacoepidemiology, Bordeaux, France
• Do Live Viral Vaccinations (Other Than Smallpox) Increase the Risk of Cardiomyopathy in Adults?
  Khromava A, Rhodes P, Shay D, Swerdlow D, Destefano F, Chen R, 20th International Conference on Pharmacoepidemiology, Bordeaux, France
• Inadvertent Rubella Vaccination during Pregnancy: Review of Reports to the U.S. Vaccine Adverse Event Reporting System (VAERS), 1991–2003.
  Calugar A, Pool V, Reef S, Zhou W, Chen RT, 20th International Conference on Pharmacoepidemiology, Bordeaux, France
• Reports of Brachial Neuritis in the Vaccine Adverse Event Reporting System (VERS), United States, 1991–2003.
  Zhou W, Pool V, Chen RT, 20th International Conference on Pharmacoepidemiology, Bordeaux, France
• Increasing complexity of vaccine safety surveillance databases: the case for “data mining”.
  J. Iskander, V. Pool, R. English-Bullard, R.T. Chen and the CDC VAERS Team, International Society of Pharmacovigilance (ISoP), Dublin, Ireland
• Yellow Fever Vaccine Safety Working Group. Thymus disease as a potential risk factor for yellow fever vaccine-associated viscerotropic disease (YEL-AVD).
  Barwick Eidex R, Miller E, Russell MN, Teuwen D, Montah T, Hayes EB, Marfin A, Iskander J, Chen R, Cetron MS, Yellow Fever Vaccine Safety Working Group, 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, Miami, FL
• Making Medical Injection Safer: A Major Step towards Enhancing Patient Safety in Developing Countries.
  Chen RT, Post G, Millogo J, Van Roekel K, Catlin M, Clark K, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Smallpox Vaccination: From Policy to Implementation.
  Offit P, Strom BL, Everett W, Riddle R, Iskander J, Chen R, 19th International Conference on Pharmacoepidemiology, Philadelphia, PA
• ASSIGN: A Proactive Systematic Approach to Vaccine-Vigilance in the U.S. Vaccine Adverse Event Reporting System.
  Pool V, James SP, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Investigation of Deaths and Serious Illnesses Following Influenza Vaccination in a Long-Term Care Facility.
  Rue AM, Lyn S, Iskander JK, Bloestein J, Gargiullo P, Shadomy S, Seward J, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Sensorineural Hearing Loss Following Measles-Mumps-Rubella Vaccination: Vaccine Adverse Event Reporting System, United States, 1991–2004.
  Asatryan A, Pool V, Chen RT, 21st International Conference on Pharmacoepidemiology, Nashville, TN
• Kenya’s “Top down approach” to improve rational injections.
  Chen RT, Songa J, Mwangi J, Lore B, Khan F, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• Fabrication and analysis of plastic hypodermic needles.
  Colton JS, Chen R, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• A model to budget for sharps waste management in resource-scarce settings.
  Chen R, Catlin M, Lasley J, Songa J, Millogo J, Ferris R, Post G, Global Injection Safety and Infection Control Meeting, Mexico City, Mexico
• AIDS Vaccines Update: Making Sense of the Vaccine Development Process – Basic Research Literacy and Lessons Learned from Vaccine History.
  Chen RT, A Collaborative Symposium in advance of the AIDS Vaccine Conference 2008, Capetown, South Africa
• Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG): Maximizing the Comparability and Value of Safety Data from HIV Vaccine Trials.
  Chen, RT; Excler JL2; Laderoute M3; Mahy B1; Hendry M1; Via Cl; Compingbutra A1; Gidudu J1 on behalf of the V3SWG, AIDS Vaccine 2009, Paris, France
• Still-blinded Safety and Immunogenicity Data from a Trial of Reduced-dose, Intradermal, Influenza Vaccination by Needle-free Jet Injection.
  Gomez V, Palomeque FS, Feris J, Fernández J, Sánchez J, Moro PL, Mota1 CS, Sánchez V, Guzmán G, Bridges CB, Bresee JS, Friede M, Zehrung D, Chen RT, Weniger BG, Thirteenth Annual Conference on Vaccine Research, Bethesda, Maryland
• Preparing for the availability of a partially effective HIV vaccine.
  Chen RT, Hankins C, Osmanov S, Esparza J, Michael NL, McCluskey M, Warren M, AIDS Vaccine 2011, Bangkok, Thailand
• Reporting Trends of Hypersensitivity Reactions in VAERS Following Live Virus Vaccines Containing Gelatin.
  Pool V, Pless RP, Chen RT, 17th International Conference on Pharmacoepidemiology, Toronto, Canada
• Enhancing the Vaccine Adverse Event Reporting System (VAERS) To Assess Risk: A Capture_Recapture Analysis of Intussusception after Rotavirus Vaccination.
  Verstraeten TM, Baughman AL, Haber P, Chen RT, 16th International Conference on Pharmacoepidemiology, Barcelona
• Join now to see all

Lectures

• CDC Perspective. 
  New York State Vaccine Safety Summit. Cooperstown, NY
• Optimal safety assessment system for future vaccines against poverty-related diseases (PRD:HIV, malaria, TB) in developing countries. 
  Meeting on Post-licensure Evaluation of Vaccine Safety: Current Status and Future Directions.
• HIV Vaccine: The Spring after a Long Winter? and A “Lifecycle” Approach to Vaccine Safety: Global Trends and Challenges. 
  5th Asian Congress of Pediatric Infectious Diseases, Taipei, Taiwan
• Vaccine Safety Strategic Issues. Distributed Networks: Opportunities and Challenges. 
  International Society of Pharmacoepidemiology Mid-Year Symposium
• Science and Practice: Establishing the Evidence for Vaccines: the intriguing tale of Diphtheria: from von Behring to Moscow. 
  ECDC, Stockholm, Sweden
• Enhancing vaccine safety assessment during vaccine development: some modest proposals. 
  2nd Global Congress on Vaccine, Boston, MA, USA
• Case Studies of possible evaluations that would use a global vaccine safety data net: HIV vaccine. 
  Global Vaccine Safety DataNet Meeting
• Plastic Hypodermic Needles: An Affordable "Green" Solution to the Iatrogenic Disaster of Unsafe Injections. 
  CDC Technology Forum, Atlanta, GA
• SIGN: some insights from inception to implementation. 
  Global Injection Safety and Infection Control Meeting
• Vaccine Safety: An Emerging Imperative. 
  Symposium of the Dutch Society for Infection Diseases, Utrecht, The Netherlands
• Immunization Safety: An Emerging Imperative. 
  American College of Clinical Pharmacy Annual Meeting, Atlanta, GA
• Symposia on Vaccine Safety. 
  Pediatric Infectious Disease Society Conference, San Diego CA
• Vaccine Safety Monitoring: A New Imperative for Immunization Programs. 
  Korean Conference on Emerging Infectious Diseases, Seoul, Korea
• Cohort and case-control studies in the evaluation of safety of vaccines. 
  The First International Symposium on The Evaluation of The Safety of Human Vaccines, Rome, Italy
• Vaccine Safety: A Cumulative Scientific Endeavor and Combination Vaccines: Meeting the New Opportunities and Challenges. 
  7th annual Massachusetts Immunization Action Partership, Worchester, MA
• Issues in Vaccine Safety. 
  41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL
• La seguridad de las vacunaciones sistemáticas. 
  First Congress of the Spanish Association of Vaccinology, Cadiz, Spain
• Maintaining Public Confidence in Immunizations: Role of Vaccine Safety at CDC. 
  AAP Chapter Advocacy Summit, Atlanta, Georgia
• Vaccine Triggers for Intussusception? and Measuring Vaccines: Benefits and Risks. 
  41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC). Chicago, IL
• Update on Vaccine Safety. 
  7th Conference of the International Society of Travel Medicine, Innsbruck, Austria
• Vaccine Safety. Vaccines are beneficial! What are the risks? 
  Berzelius symposium on vaccines, Stockholm, Sweden
• Update on Vaccine Safety Monitoring in the U.S.: Sustaining Mature Immunization Programs. 
  World Vaccine Congress, Paris, France
• Establishing Causality in Vaccine Safety Studies: Lines of Evidence. 
  Pan American Health Organization (PAHO), (EPI), (TAG) Meeting, Iguasu Falls, Brazil
• Vaccine Safety Update. 
  Association of State and Territorial Health Officials (ASTHO) Infectious Disease Policy Committee
• Join now to see all

Other

• Infant Immunization With Acellular Pertussis Vaccines in the United States:Assessment of the First Two Years' Data From the Vaccine Adverse Event Reporting System (VAE... 
  Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS, and the VAERS Working Group, Pediatrics 2000;106(4)
  http://www.pediatrics.org/cgi/content/full/106/4/e51
• Surveillance for poliovirus vaccine adverse events, 1991-1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral polioviru... 
  Wattigney WA, Mootrey GT, Braun MM, Chen RT, Pediatrics 2001;107(5)
  http://www.pediatrics.org/cgi/content/full/107/5/e83
• Childhood vaccinations, vaccination timing, and risk of type 1 diabetes mellitus. 
  DeStefano F, Mullooly J, Okoro K, Chen RT, Vadheim C, Marcy M, Ward J, Black S, Shinefield H, Davis R, Bohlke K, Pediatrics 2001; 108(6)
  http://www.pediatrics.org/cgi/content/full/108/6/e112
• A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use and measles-mumps-rubella vaccination. 
  Verstraeten T, Jumaan A, Mullooly J, Seward J, Izurieta H, DeStefano F, Black S, Chen R, and the Vaccine Safety Datalink Research Group, Pediatrics 2003 Aug;112:e98 –e103
  http://www.pediatrics.org/cgi/content/full/112/2/e98
• The Brighton Collaboration: Creating a Global Standard for Case Definitions (and Guidelines) for Adverse Events Following Immunization. Advances in Patient Safety: Fr... 
  Kohl K, Bonhoeffer J, Braun MM, Chen R, Duclos P, Heijbel H, Heininger U, Loupi E, Marcy SM, and The Brighton Collaboration, AHRQ Publication Nos. 0500212
  http://www.ahrq.gov/qual/advances/
  Agency for Healthcare Research and Quality, Rockville, MD
• Join now to see all